| Immunophenotype | n/N (%) |
| CD3+ | 24/24 (100%) |
| CD4+CD8+ | 20/20 (100%) |
| CD4+/CD8+ > 1 | 8/20 (40%) |
| CD4+/CD8+ < 1 | 6/20 (30%) |
| CD20+ | 7/21 (33.3%) |
| CD56+ | 8/21 (38.1%) |
| CD30+ | 10/18 (55.6%) |
| TIA-1+ | 18/18 (100%) |
| EBER positive | 28/29 (96.6%) |
| EBER > 100δΈͺ/HPF | 8/29 (27.6%) |
| Ki-67 (%) | 10%~90% |
| TCR positive | 5/10 (50%) |